Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Evidence that expression of SpαI/65 hereditary elliptocytosis is compounded by a genetic factor that is linked to the homologous α-spectrin allele

Summary

Many cases of hereditary elliptocytosis (HE) result from mutated spectrin α-chains. It has repeatedly been observed that the amount of a mutant α-chain is different in various affected individuals, resulting in clinical pictures of variable severity. The different levels are thought to result from different percentages of the αspectrin allele in trans. Such percentages, in turn, could be under genetic control. We tested this hypothesis in a large Algerian family with SpαI/65 HE. In an informative sibship, we found three persons with a distinctly high level of expression of the SpαI/65 variant, suggesting the existence, in trans, of a low percentage α-allele. The α-spectrin gene haplotype associated with the latter was constantly − +−, based on the XbaI, PvuII and MspI polymorphic sites. In contrast, a basal level of expression of the SpαI/65 variant in the same sibship indicated, in trans, the existence of a normal percentage α-allele. The haplotype corresponding to this other α-allele was + − +. Study of another generation of the family showed, however, that the − + − haplotype could also be linked to a normal percentage α-allele. These results are consistent with the view that the expression level of αI/65 spectrin (and of other types of α-variants) is compounded by a genetic factor that is linked to the normal α-allele in trans. The low percentage allele itself remains silent in the simple heterozygous state.

This is a preview of subscription content, log in to check access.

References

  1. Alloisio N, Guetarni D, Morlé L, Pothier B, Ducluzeau MT, Soun A, Colonna P, Clerc M, Philippe N, Delaunay J (1986) SpαI/65 hereditary elliptocytosis in North Africa. Am J Hematol 23: 113–122

  2. Delaunay J, Alloisio N, Morlé L, Pothier B (1990) The red cell skeleton and its genetic disorders. In: Baum H, Gergely J, Fanburg BL (eds) Molecular aspects of medicine, vol 11. Pergamon Press, Oxford, pp 161–241

  3. Hoffman N, Stanislovitis P, Watkins PC, Klinger KW, Linnenbach AJ, Forget BG (1987) Three RFLPs are detected by an alpha spectrin genomic clone. Nucleic Acids Res 15: 4696

  4. Lawler J, Coetzer TL, Jacob HS, Luban N (1985) SpαI/65: a new variant of the α subunit of spectrin in hereditary elliptocytosis. Blood 66: 706–709

  5. Lecomte MC, Dhermy D, Solis C, Ester A, Féo C, Gautero H, Bournier O, Boivin P (1985) A new abnormal variant of spectrin in black patients with hereditary elliptocytosis. Blood 65: 1208–1217

  6. Linnenbach AJ, Speicher DW, Marchesi VT, Forget BG (1986) Cloning of a portion of the chromosomal gene for human erythrocyte α-spectrin by using a synthetic gene fragment. Proc Natl Acad Sci USA 83: 2397–2401

  7. Marchesi SL (1989) The erythrocyte cytoskeleton in hereditary elliptocytosis and spherocytosis. In: Agre P, Parker JC (eds) Red blood cell membranes. (Hematology, vol 11) Dekker, New York, pp 77–110

  8. Marchesi SL, Letsinger JT, Speicher DW, Marchesi VT, Agre P, Hyun B, Gulati G (1987) Mutant forms of spectrin α-subunits in hereditary elliptocytosis. J Clin Invest 80: 191–198

  9. Palek J (1985) Hereditary elliptocytosis and related disorders. Clin Haematol 14: 45–87

  10. Palek J (1987) Hereditary elliptocytosis, spherocytosis and related disorders: consequences of a deficiency or a mutation of membrane skeletal proteins. Blood Rev 1: 147–168

  11. Roux AF, Morlé F, Guetarni D, Colonna P, Sahr K, Forget BG, Delaunay J, Godet J (1989) Molecular basis of SpαI/65 hereditary elliptocytosis in North Africa: insertion of a TTG triplet between codons 147 and 149 in the α-spectrin gene from five unrelated families. Blood 73: 2196–2201

  12. Sahr KE, Tobe T, Scarpa A, Laughinghouse K, Marchesi SL, Agre P, Linnenbach AJ, Marchesi VT, Forget BG (1989) Sequence and exon-intron organization of the DNA encoding the αI domain of human spectrin. Application to the study of mutations causing hereditary elliptocytosis. J Clin Invest 84: 1243–1252

  13. Sahr KE, Garbarz M, Dhermy D, Lecomte MC, Boivin P, Agre P, Laughinghouse K, Scarpa A, Coetzer T, Palek J, Marchesi SL, Forget BG (1990) Use of the polymerase chain reaction for the detection and characterization of mutations causing hereditary elliptocytosis. In: Cohen CM, Palek J (eds) Cellular and molecular biology of normal and abnormal erythroid membranes. (UCLA Symposia on molecular and cellular biology, new series, vol 118) Liss, New York, pp 201–210

  14. Speicher W, Morrow J, Knowles WI, Marchesi VT (1982) A structural model of human erythrocyte spectrin: alignment of chemical and functional domains. J Biol Chem 257: 9093–9101

  15. Stanislovitis P, Watkins PC, Chang G, Coupai E, Costa FF, Winkelmann J, Agre P, Marchesi VT, Forget BG (1989) A cDNA for human erythroid β-spectrin (SPTB) detects an RFLP (abstract). (10th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 51: 1085

  16. Winkelmann JC, Leto TL, Watkins PC, Eddy R, Shows TB, Linnenbach AJ, Sahr KE, Kathuria N, Marchesi VT, Forget BG (1988) Molecular cloning of the cDNA for human erythrocyte β-spectrin. Blood 72: 328–334

Download references

Author information

Correspondence to A.-F. Roux.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Guetarni, D., Roux, A., Alloisio, N. et al. Evidence that expression of SpαI/65 hereditary elliptocytosis is compounded by a genetic factor that is linked to the homologous α-spectrin allele. Hum Genet 85, 627–630 (1990). https://doi.org/10.1007/BF00193587

Download citation

Keywords

  • Internal Medicine
  • Metabolic Disease
  • Genetic Factor
  • Clinical Picture
  • Genetic Control